Project Grant 2423382

Award Date 1/1/25
Completion Date 8/31/25
Dollars Obligated $275K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Excelsior, MN 55331, USA
Similar Awards
This $274,797 National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Deepseq.ai LLC supports the development of an AI-driven platform to accelerate the identification of highly developable single-domain antibodies for drug discovery. The proposed work aims to create a multimodal AI model capable of rapidly screening large libraries to generate lead molecules with favorable binding affinity, stability, and manufacturability. This project...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is providing $275,000 to Dinya DNA Inc. to support the commercial development of a novel DNA synthesis technology. The key products or services being delivered include: Developing new methods to ensure higher fidelity DNA precursors, which are the building blocks for DNA synthesis Reducing synthesis costs by streamlining the DNA synthesis...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $294,947 to Percept Biosciences Inc. located in San Diego, CA. The funding will support the development of a software tool to automate the creation of drug repurposing development plans. The tool aims to accelerate the drug repurposing process by integrating relevant data sources, optimizing drug targets and candidates, and generating...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to develop a new, highly automated, and low-cost method for producing long synthetic DNA molecules. The $295,923 award to Avery Digital Data, Inc. will fund research into using electronic nanochannel chip devices to precisely control the motion of DNA fragments and enable the assembly of longer, gene-length DNA constructs....
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program award provides $274,990 to Dencoda LLC to develop a novel DNA-based kinase assay platform. The key products to be delivered are: A highly sensitive, specific, and multiplexed kinase activity assay that can be used as a research tool to discover new therapeutic targets or as a clinical diagnostic test for diseases involving kinase dysregulation, such as cancers, diabetes, and Alzheimer's...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Om Therapeutics Inc. to develop innovative technology for the high-throughput screening of small molecule and protein interactions. The project aims to enable the rapid and cost-effective discovery of new medicines by encapsulating proteins and small molecules in millions of barcoded micro-compartments to identify specific...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $275,000 will support the development of a plasmonic nanopore sensor device for quality control of adeno-associated viruses (AAVs) used in gene therapy. The proposed device will enable accurate characterization of AAV payload (single-stranded DNA, double-stranded DNA, or empty) at low, pre-scale-up concentrations to optimize formulations. The project aims to demonstrate the...
The National Science Foundation (NSF) awarded Pearl Bio, Inc., a biotechnology company, a $274,462 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funded the development of a next-generation biomanufacturing platform to engineer new microbial organisms and cellular machinery. This platform enables the incorporation of diverse, non-native components into proteins, creating a new class of biological materials for therapeutic development,...
This $256,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program will support the development of a universal connector for high-density microfluidic chip interfaces by Neptune Fluid Flow Systems LLC. The proposed connector aims to advance lab-on-a-chip and other life science platforms by introducing a standardized microfluidic chip interface. This new interface seeks to dramatically increase diagnostic testing speeds for doctors and...
The National Science Foundation (NSF) awarded a $600,000 Project Grant under the Computer and Information Science and Engineering program (CFDA 47.070) to Trustees of Dartmouth College to support the development of an "Emerging Technology Tool for Rapid Drug-Cocktail Formulation." The project aims to create a technology platform that leverages the mathematical equivalence between biological and electronic circuits to enable rapid, high-throughput discovery of optimal drug cocktails...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $274,932 to Femtofluidics Incorporated to develop hardware that can rapidly and inexpensively synthesize DNA-encoded libraries (DELs) for drug discovery. The project aims to create an electronic device that can manipulate nanoliter to picoliter volume droplets to perform combinatorial chemistry, overcoming limitations of traditional liquid-handling robots. This technology has the potential to accelerate drug development, generate data to improve AI drug prediction models, and enhance U.S. competitiveness in drug discovery and automation. The award period is from January 1, 2025 to August 31, 2025. No sub-awards are planned under this project.

Generated 4/8/25, 4:33 AM